Lisinopril Pellets

(Product under development)
Lisinopril Pellets Lisinopril is a drug of the angiotensin-converting enzyme (ACE) inhibitor class that is primarily used in treatment of hypertension,congestive heart failure, and heart attacks and also in preventing renal and retinalcomplications of diabetes.

Its indications, contraindications and side effects are as those for all ACE inhibitors. It has been compared with omapatrilat, which is of similar function.

Historically, lisinopril was the third ACE inhibitor (after captopril and enalapril) and was introduced into therapy in the early 1990s.

Lisinopril has a number of properties that distinguish it from other ACE inhibitors: It is hydrophilic, has a long half-life and tissue penetration, and is not metabolized by the liver.

Availble Form:
Lisinopril IR Pellets
Lisinopril Granules

Umang Pharmatech equipments used for production of Lisinopril Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Lisinopril Pellets
Systematic (IUPAC) Name
Lisinopril Pellets
Identifiers
Lisinopril Pellets
Chemical data
N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline
CAS number : 83915-83-7
ATC code : C09AA03
PubChem : CID 5362119
DrugBank : APRD00560
ChemSpider : 4514933
UNII : 7Q3P4BS2FD
KEGG : D00362
ChEMBL : CHEMBL1237
Formula : C21H31N3O5
Mol. mass : 405.488 g/mol


* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech
TESTIMONIAL